Showing 100 of 100on this page. Filters & sort apply to loaded results; URL updates for sharing.100 of 100 on this page
HEPCLUDEX 2 mg POWDER FOR INJECTABLE SOLUTION leaflet – Spain | Oladoctor
FDA Approves Hepcludex as First and Only Approved Treatment for Chronic ...
FDA rejects Gilead's hepatitis D therapy Hepcludex | pharmaphorum
The new hepatitis D drug Hepcludex is launched, develops HBV/HDV entry ...
NEW PRODUCT: Hepcludex for hepatitis D | Canadian Healthcare Network
Public Summary SwissPAR Hepcludex ENG | PDF | Hepatitis | Medical ...
Hepcludex (bulevirtida) | Relatório de avaliação de financiamento ...
FDA Approves Gilead's Hepcludex for Chronic Hepatitis Delta Virus ...
Hepcludex (bulevirtide) dosing, indications, interactions, adverse ...
Hepcludex 2mg (Bulevirtide) – e-prescription in Spain | Oladoctor
Hepcludex Bulevirtide medicine overview section translation memory ...
Hepcludex Bulevirtide acetate MYR GmbH product information translation ...
Hepcludex IG Post - Hepatitis B Foundation
Hepcludex Injection guide - Gilead - Academy
Hepcludex Injektionsanleitung - Gilead - Academy
HEPCLUDEX 2 mg pdre p sol inj - VIDAL
GileadPro | Hepcludex
HEPCLUDEX (Pulver till injektionsvätska, lösning 2 mg) • Bipacksedel ...
Аюлгүй болон эмчилгээниий ѳндѳр үр дүнтэй гэж баталгаажсан HEPCLUDEX ...
HEPCLUDEX - FASS Allmänhet
Hepcludex: Uses, Dosage, Side Effects & Warnings - Drugs.com
Biopharma News: Approvals, Appeals, and AI
Hepcludex® (Bulevirtide) Demonstrates Sustained Efficacy and Safety ...
New Nature Publication by Akribion Therapeutics GmbH: RNA-triggered ...
Need to Act on Hepatitis D Now | HepSA Community News
CHMP Adopts Positive Opinion Recommending Hepcludex® for Full Marketing ...
If You Have Chronic Hepatitis B, a New FDA Approval Means You Should ...
Pharmaceutical Business Review International on LinkedIn: # ...
Maviret now approved in EU for acute hepatitis C virus infections
Bulevirtide plus Peginterferon for Chronic Hepatitis D | New England ...
FDA Issues Early Alert for Boston Scientific's Stent and Electrocautery ...
Hepcludex® (bulevirtide) - News, Articles etc. - European ...
BULEVIRTIDE (Myrcludex-B, Hepcludex) the mechanism of action - YouTube
Hepcludex: First drug for hepatitis D has been approved | German Center ...
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and ...
P128 Real world experience with Bulevirtide (Hepcludex ®): results from ...
Hepcludex用于慢性丙型肝炎(Hepatitis D) - 知乎
吉利德科學HDV療法Hepcludex獲美國FDA加速核准 肝病治療迎突破 - 商傳媒
Biotech Stocks Facing FDA Decision In June 2026
首款!吉利德肝炎新药Hepcludex获批FDA 近日(5月22日),FDA宣布加速批准吉利德的Hepcludex(Bulevirtide ...
Comisia Europeană aprobă bulevirtide, primul medicament pentru ...
Bulevirtide Shows Promise in Tough-to-Treat Hepatitis D | MedPage Today
全球丁肝治疗药物:吉利德Hepcludex(bulevirtide)在美国申请上市,已在欧盟获批! - 专区 - 生物谷
丁型肝炎新药Hepcludex (bulevirtide)获EMA完全上市许可医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
La OMS incluye 35 nuevos medicamentos esenciales: consulta aquí el ...
47-Amino Acid Peptide Bulevirtide for The Treatment of Chronic ...
Hepcludex: Erstes Medikament für Hepatitis D zugelassen | Deutsches ...
Latest Medical News News | MedPage Today
Detail - Gilead - Academy
丁肝新藥HEPCLUDEX,歐洲首個獲批,德國法國奧地利上市 - 每日頭條
快讯 | Gilead 丁肝治疗肽Bulevirtide关键Ⅲ期临床数据公布 - 知乎
Europe’s Innovation Edge? | PharmExec
吉利德的慢丁肝治疗药物 | 全球首个针对慢性丁型肝炎病毒感染的病毒进入抑制剂Hepcludex (bulevirtide) - 知乎
Blocking viral entry with bulevirtide reduces the number of HDV ...
Broschyrer och hjälpmedel
Reflex Aerospace Secures Record €50 Million Series A
Hepcludex(布仑韦肽 Bulevirtid)首个针对乙肝合并丁肝感染的入侵抑制药物 - 知乎
Star Citizen Funding Soars, 2025 Its Most Successful Year
Мирклудекс Б(Bulevirtide)布列维肽 | 百配健康-阅读越健康!
Hepatitis&More: Hepcludex® (Bulevirtid)
Hepcludex® - Gilead - Academy
Clinical Pharmacology of Bulevirtide: Focus on Known and Potential Drug ...
进展|斐铁嘉(头孢德罗)中国获批治疗复杂性尿路感染(cUTI) | 百配健康-阅读越健康!
Smartbax erweitert Finanzierungsrunde
Эм, - ЭЛЭГНИЙ Д ВИРУСИЙН ЭСРЭГ ЭМИЙГ ӨНЧИН ЭМИЙН ЖАГСААЛТАНД ОРУУЛАХЫГ ...
台灣肝炎資訊及病友權益 - 第一個治療D肝的藥物 #Bulevirtide 在歐盟上市了! 此藥的商品名稱叫...
Gilead T1 2026 : la croissance du VIH stimule les prévisions malgré les ...